Study Name: Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection
27 locations found
- 205.479.01017 Boehringer Ingelheim Investigational Site
Location: Tucson, Arizona
- 205.479.01036 Boehringer Ingelheim Investigational Site
Location: Riverside, California
- 205.479.01024 Boehringer Ingelheim Investigational Site
Location: San Diego, California
- 205.479.01043 Boehringer Ingelheim Investigational Site
Location: DeLand, Florida
- 205.479.01040 Boehringer Ingelheim Investigational Site
Location: St. Petersburg, Florida
- 205.479.01022 Boehringer Ingelheim Investigational Site
Location: Chelsea, Michigan
- 205.479.01041 Boehringer Ingelheim Investigational Site
Location: Picayune, Mississippi
- 205.479.01037 Boehringer Ingelheim Investigational Site
Location: St. Louis, Missouri
- 205.479.01005 Boehringer Ingelheim Investigational Site
Location: Tabor City, North Carolina
- 205.479.01008 Boehringer Ingelheim Investigational Site
Location: Wilmington, North Carolina
- 205.479.01003 Boehringer Ingelheim Investigational Site
Location: Cincinnati, Ohio
- 205.479.01002 Boehringer Ingelheim Investigational Site
Location: Pittsburgh, Pennsylvania
- 205.479.01044 Boehringer Ingelheim Investigational Site
Location: Tipton, Pennsylvania
- 205.479.01006 Boehringer Ingelheim Investigational Site
Location: Charleston, South Carolina
- 205.479.01001 Boehringer Ingelheim Investigational Site
Location: Columbia, South Carolina
- 205.479.01007 Boehringer Ingelheim Investigational Site
Location: Easley, South Carolina
- 205.479.01026 Boehringer Ingelheim Investigational Site
Location: Fort Mill, South Carolina
- 205.479.01031 Boehringer Ingelheim Investigational Site
Location: Gaffney, South Carolina
- 205.479.01012 Boehringer Ingelheim Investigational Site
Location: Greenville, South Carolina
- 205.479.01048 Boehringer Ingelheim Investigational Site
Location: Hodges, South Carolina
- 205.479.01004 Boehringer Ingelheim Investigational Site
Location: Spartanburg, South Carolina
- 205.479.01019 Boehringer Ingelheim Investigational Site
Location: Union, South Carolina
- 205.479.01039 Boehringer Ingelheim Investigational Site
Location: Rapid City, South Dakota
- 205.479.01033 Boehringer Ingelheim Investigational Site
Location: Chattanooga, Tennessee
- 205.479.01028 Boehringer Ingelheim Investigational Site
Location: Killeen, Texas
- 205.479.01038 Boehringer Ingelheim Investigational Site
Location: Ettrick, Virginia
- 205.479.01047 Boehringer Ingelheim Investigational Site
Location: Norfolk, Virginia
|